Evidence map›Paper›PMID 34787456›Full record

ArticleJournal of virology2022

The Antimalaria Drug Artesunate Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by Activating AMPK and Nrf2/HO-1 Signaling Pathways.

Feixiang Long, Mingxin Zhang, Xia Yang, Xiaohuan Liang, Lizhan Su, Tongqing An, Guihong Zhang, Zhenling Zeng, Yahong Liu, Weisan Chen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Feixiang LongGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.
Mingxin ZhangGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.
Xia YangGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.
Xiaohuan LiangGuangdong Laboratory for Lingnan Modern Agriculture, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.
Lizhan SuGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.
Tongqing AnState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Republic of China.
Guihong ZhangGuangdong Laboratory for Lingnan Modern Agriculture, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.
Zhenling ZengGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.
Yahong LiuGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.
Weisan ChenDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia.
Jianxin ChenGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural Universitygrid.20561.30, Guangzhou, People's Republic of China.ORCID 0000-0002-2978-1248
South China Agricultural University · CNChinese Academy of Agricultural Sciences · CNLa Trobe University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) causes significant economic losses to the pork industry worldwide. Currently, vaccine strategies provide limited protection against PRRSV transmission, and no effective drug is commercially available. Therefore, there is an urgent need to develop novel antiviral strategies to prevent PRRSV pandemics. This study showed that artesunate (AS), one of the antimalarial drugs, potently suppressed PRRSV replication in Marc-145 cells and

Indexed as

Adenosine DiphosphateAdenosine MonophosphateAdenosine TriphosphateAMP-Activated Protein KinasesAnimalsAntimalarialsArtesunateCell LineDisease SusceptibilityHeme Oxygenase-1Host-Pathogen InteractionsModels, BiologicalNF-E2-Related Factor 2Porcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusSignal TransductionAdenosine DiphosphateAdenosine MonophosphateAdenosine TriphosphateAMP-Activated Protein KinasesAntimalarialsArtesunateHeme Oxygenase-1NF-E2-Related Factor 2AMPKartesunate (AS)inhibitorNrf2/HO-1porcine reproductive and respiratory syndrome virus (PRRSV)

Identifiers

PMID34787456
PMCPMC8826906
OpenAlexW3213085184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.